Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winnie Siu

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Vaccine|July 30, 2024
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infantsGebremedhin B Gebretekle, Man Wah Yeung, Raphael Ximenes, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 9, 2024
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysisAshleigh R Tuite, Alison E Simmons, Monica Rudd, et al.
American Journal of Public Health|February 26, 2015
A systematic review of randomized controlled trials of interventions to improve the health of persons during imprisonment and in the year after releaseFiona G Kouyoumdjian, Kathryn E McIsaac, Jessica Liauw, et al.
Plos One|June 12, 2026
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysisGebremedhin B Gebretekle, Marie Lan, Min Xi, et al.
BMJ Evidence-Based Medicine|April 11, 2024
Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysisAreti Angeliki Veroniki, Sai Surabi Thirugnanasampanthar, Menelaos Konstantinidis, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Vaccine|July 30, 2024
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infantsGebremedhin B Gebretekle, Man Wah Yeung, Raphael Ximenes, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 9, 2024
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysisAshleigh R Tuite, Alison E Simmons, Monica Rudd, et al.
American Journal of Public Health|February 26, 2015
A systematic review of randomized controlled trials of interventions to improve the health of persons during imprisonment and in the year after releaseFiona G Kouyoumdjian, Kathryn E McIsaac, Jessica Liauw, et al.
Plos One|June 12, 2026
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysisGebremedhin B Gebretekle, Marie Lan, Min Xi, et al.
BMJ Evidence-Based Medicine|April 11, 2024
Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysisAreti Angeliki Veroniki, Sai Surabi Thirugnanasampanthar, Menelaos Konstantinidis, et al.
Pageof 3